Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Thijn Brummelkamp

Co-founder, Scenic Biotech

Thijn Brummelkamp studied biology at the Free University in Amsterdam and did his graduate studies at The Netherlands Cancer Institute (in the group of René Bernards). After his PhD he was appointed as group leader (Whitehead Fellow) at the Whitehead Institute for Biomedical Research in Cambridge, USA. In 2011 his laboratory moved to the Netherlands Cancer Institute in Amsterdam.
Thijn Brummelkamp develops and uses genetic technologies to identify genes that are relevant for human disease. For example an approach for genetics in haploid human cells was developped and used to identify the entry receptor for Ebola virus (Carette et al, Nature, 2011), to reognize a new step in the picornavirus life cycle (Staring et al, Nature, 2017), to assign Vasohibins as long-sought enzymes modifiers of the cytoskeleton (Nieuwenhuis et al, Science 2017) and to implicate genes in pathways relevant for cancer immunotherapy (Mezzadra et al, Nature, 2017; Logtenberg et al, Nature Medicine, 2019).

He was chosen as one of the world's top 35 Young Innovators by MIT's Technology Review Magazine (2005), received EMBO’s Gold Medal 2013 and the KNAW Ammodo award (2015). Thijn Brummelkamp is a co-founder of 3 biotech companies, Haplogen Genomics (acquired in 2015 by Horizon Discovery UK), Haplogen (partnered in 2018 with Bayer to develop antiviral agents) and Scenic Biotech B.V. (founded in 2017).

Title: From basic research to application

The abstract will follow soon.
Dharminder Chalal
SkylineDx
Marcel Levi
University College London Hospitals
Michel Dumontier
Maastricht University
Thijn Brummelkamp
Scenic Biotech
Hans Schikan
Topsector Life Sciences & Health
Inge Huitinga
Netherlands Brain Bank
Sjaak Vink
TheSocialMedwork
Annemarie Jorritsma
NVP
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Tim Knotnerus
AgomAb Therapeutics
Elise Meijer
Antwerp Management School & Accenture Strategy
Esther Talboom-Kamp
Saltro Diagnostics
Joep Muijrers
PureTech Health
Els Beirnaert
Aelin Therapeutics
Carine van den Brink
Axon Lawyers

Claudia Rijcken
pharmi

Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.